You are viewing: UK Nuclear Medicine Equipment Market analysis

The UK Nuclear Medicine Equipment Market was valued at $268 Million in 2025 and projected to reach to $346 Million by 2030, representing a compound annual growth rate of 5.2%. The UK nuclear medicine equipment market is positioned for steady growth, supported by NHS modernisation initiatives and increasing clinical demand for advanced diagnostic imaging.

UK Nuclear Medicine Equipment Market (2025-2030) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

UK Nuclear Medicine Equipment Market Trends and Insights

  • The UK market benefits from advanced healthcare infrastructure, strong NHS investment in diagnostic imaging, and increasing adoption of hybrid imaging technologies such as PET-CT and SPECT-CT systems.
  • The UK's aging population and rising prevalence of chronic diseases drive demand for nuclear medicine diagnostics and therapeutic equipment. In the UK, regulatory support through the Medicines and Healthcare products Regulatory Agency (MHRA) and growing clinical evidence for nuclear medicine procedures support market expansion between 2025 and 2030.
  • The UK market is characterized by established players, significant hospital and imaging center investments, and a shift toward personalized medicine and targeted radionuclide therapies.
  • The UK's commitment to modernizing NHS imaging capabilities and increasing reimbursement for advanced nuclear medicine procedures positions the country as a key growth market within Europe..

Key Market Statistics

  • CAGR (2025-2030) 5.2% CAGR
  • Market Size, 2025 ~USD 268 Million
  • Forecast, 2030 ~USD 346 Million
  • Country UK

UK Nuclear Medicine Equipment Market Overview

Strong NHS Investment :

The UK National Health Service continues to allocate significant capital expenditure towards modernising diagnostic imaging departments, driving demand for advanced nuclear medicine equipment across NHS trusts and private healthcare facilities.

Hybrid Imaging Adoption :

UK hospitals are increasingly adopting PET-CT and SPECT-CT hybrid systems, which combine anatomical and functional imaging capabilities, improving diagnostic accuracy and patient outcomes in oncology, cardiology, and neurology applications.

Ageing Population Demographics :

The UK's ageing population is driving higher prevalence of chronic diseases including cancer, cardiovascular conditions, and neurological disorders, necessitating increased nuclear medicine diagnostic procedures and equipment demand.

Regulatory Excellence & Standards :

The UK maintains stringent regulatory frameworks through the Care Quality Commission and MHRA, ensuring high standards for nuclear medicine equipment, which supports market confidence and drives investment in quality diagnostic solutions.

UK Nuclear Medicine Equipment Market Dynamics

  • The shift towards hybrid imaging technologies and personalised medicine approaches will continue to drive equipment upgrades across major hospital networks.
  • Regulatory support and reimbursement policies favour nuclear medicine procedures, particularly in oncology and cardiology.
  • By 2030, the market is expected to reach $346 million, reflecting sustained investment in healthcare infrastructure and technological advancement.
  • Private healthcare expansion and specialist imaging centres will further contribute to market expansion throughout the forecast period..

Related Ecosystem

Pharmaceuticals

Top Technologies
  • Bioreactors
  • Analytical Testing
  • Bioanalytical Testing Services
  • Cell Counters
  • Data Management Services
Top Companies
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • SANOFI
  • Pfizer Inc.
  • NOVARTIS

    Key Takeaways

    • The UK nuclear medicine equipment market is valued at $268.0 million in 2025 and will reach $346.0 million by 2030, growing at 5.2% CAGR.
    • The UK's advanced healthcare infrastructure and NHS investment in diagnostic imaging drive strong demand for PET-CT and SPECT-CT hybrid systems.
    • The UK's aging population and rising chronic disease prevalence increase demand for nuclear medicine diagnostics and therapeutic equipment.
    • Regulatory support from the MHRA and growing clinical evidence for nuclear medicine procedures support sustained market growth in the UK through 2030.

    Nuclear Medicine Equipment Market Report Scope

    Report Metric Details
    Base Year 2025
    Fastest Growing Segment DIAGNOSTIC IMAGING CENTERS (End User)
    Forecast Period 2025–2030
    Growth Rate CAGR of 4.62% from 2025 to 2030
    Largest Segment IMAGING MODALITIES (System Type)
    Market Size Base Year (Billions) ~USD 6.63 (2025)
    Revenue Forecast (Billions) ~USD 8.31 (2030)
    Segments Covered System Type, Type, Therapeutic Area, Dimension, End User, Type 2023–2030

    UK Nuclear Medicine Equipment Market Report Segmentation

    6 segment dimensions are covered across the global market.

    By System Type

    • Imaging Modalities
    • Non- Imaging Modalities
    • Non-Imaging Modalities

    By Type

    • Dose Calibrators
    • Gamma Well Counters
    • Gamma/ Scintillation Cameras
    • Gamma/Scintillation Cameras
    • Gm Counters
    • Hybrid Pet
    • Hybrid Spect
    • Other Non-Imaging Modalities
    • Pet
    • Probe Counting Systems
    • Spect
    • Standalone Pet
    • Standalone Spect

    By Therapeutic Area

    • Cardiology
    • Neurology
    • Oncology
    • Orthopedics
    • Other Therapeutic Areas
    • Thyroid

    By Dimension

    • 2D
    • 3D

    By End User

    • Cancer Treatment Centers
    • Diagnostic Imaging Centers
    • Hospitals
    • Other End Users

    By Type 2023–2030

    • Dose Calibrators
    • Gamma Well Counters
    • Gamma/ Scintillation Cameras
    • Gm Counters
    • Other Non-Imaging Modalities
    • Pet
    • Probe Counting Systems
    • Spect

    UK: NUCLEAR MEDICINE EQUIPMENT MARKET, BY END USER, 2023–2030

    Segment20232024202520262027202820292030CAGR (%)
    CANCER TREATMENT CENTERS35.137.139.241.443.846.248.851.45.6
    DIAGNOSTIC IMAGING CENTERS49.752.755.859.162.666.370.274.25.9
    HOSPITALS133.8140.8148155.6163.4171.7180.3189.25
    OTHER END USERS22.723.824.926.127.328.529.831.14.5
    TOTAL241.3254.4268282.2297.1312.73293465.2

    Target Audience

    • Medical Device Manufacturers : Equipment manufacturers need UK-specific market data to develop localised product strategies, understand NHS procurement requirements, and identify partnership opportunities with distributors and hospital networks.
    • Healthcare Facility Administrators : Hospital and clinic managers require market insights to justify capital equipment investments, benchmark against peer institutions, and plan diagnostic imaging department upgrades aligned with clinical demand trends.
    • Investment & Private Equity Firms : Investors evaluating healthcare sector opportunities need detailed UK market analysis to assess growth potential, identify acquisition targets, and understand regulatory risks in the nuclear medicine equipment space.
    • Healthcare Consultants & Advisors : Consulting firms advising NHS trusts and private providers require comprehensive market data to develop strategic recommendations, optimise capital allocation, and support technology adoption planning.
    • Distributors & Service Providers : Equipment distributors and service companies need UK market segmentation data to identify high-potential customer segments, plan inventory strategies, and develop targeted sales and support programmes.

    Key Companies in the UK Nuclear Medicine Equipment Market

    CompanyHQOwnershipStrongest segments
    PHILIPSNetherlandsPublic CompanyImaging Systems (PET, SPECT, Gamma),Software (Image Management, PACS, Treatment, Analytics, Workflow),Detectors & Counters (GM Counter, Dose Calibrator and Related),
    DIGIRAD CORPORATIONUnited StatesPrivate CompanyImaging – SPECT / Gamma cameras,Imaging – PET,Radiation detection (GM counters, dose calibrators),
    TOSHIBA CORPORATIONJapanPrivate CompanyImaging Equipment (PET, SPECT, Gamma),Radiation Measurement (GM Counter, Dose Calibrator),Software (Image Management, PACS, Treatment, Analytic, Workflow),
    SIEMENS AGGermanyPublic CompanyImaging Systems (PET, SPECT, Gamma Cameras),Software (Image Management, PACS, Treatment, Analytics, Workflow),Therapy-adjacent Solutions (Onco, Cardio, Neuro, Ortho Planning/Support),
    GE HEALTHCAREUnited StatesPublic CompanyImaging – PET,Imaging – SPECT,Imaging – Gamma cameras,
    SIEMENS HEALTHINEERS AGGermany
    KONINKLIJKE PHILIPS N.V.NetherlandsPublic CompanyImaging Systems (PET, SPECT, Gamma Cameras),Software (Image Management, PACS, Analytics, Workflow, Treatment Planning Interfaces),Therapy-related Applications (Oncology, Cardiology, Neurology, Orthopedic Planning),
    MIRION TECHNOLOGIES, INC.United StatesPublic CompanyImaging-related equipment (PET/SPECT/Gamma-adjacent QA, detectors, cameras),Radiation measurement & counters (GM counters, dose calibrators, health-physics),Software (image/spectroscopy analysis, QA, workflow, treatment support),
    DOSISOFT SAFrancePrivate CompanyImaging-related software (PET/SPECT/Gamma image management & PACS integration),Treatment planning & dosimetry software (Onco/Cardio/Neuro/Ortho),Analytics & workflow orchestration,
    SEGAMI CORPORATIONJapanPrivate CompanyImaging Equipment (PET/SPECT/Gamma),GM Counters & Dose Calibrators,Nuclear Medicine Software (Image Management, PACS, Treatment, Analytic, Workflow),
    LABLOGIC SYSTEMS LTD.United KingdomPrivate CompanyImaging-adjacent QC hardware (gamma counters, dose calibrator-related QC, radiochromatography hardware),CDS / Image & data management software for radiopharmaceutical workflows,LIMS / workflow and analytic software for nuclear medicine and radiochemistry labs,

    PHILIPS

    Philips is a Dutch multinational public company founded in 1891 with 63,670 employees. The company operates across healthcare, consumer lifestyle, and lighting sectors.

    DIGIRAD CORPORATION

    Digirad Corporation is a United States-based private company founded in 1985 with 194 employees.

    TOSHIBA CORPORATION

    Toshiba Corporation is a Japanese private company founded in 1875 with 106,648 employees, operating across multiple industrial and technology sectors.

    SIEMENS AG

    Siemens AG is a German public company founded in 1847 with 310,312 employees, operating across industrial, infrastructure, and healthcare sectors.

    GE HEALTHCARE

    GE Healthcare is a United States-based public company founded in 2022 with 54,000 employees.

    SIEMENS HEALTHINEERS AG

    Siemens Healthineers AG is a German healthcare company within the Siemens group.

    KONINKLIJKE PHILIPS N.V.

    Koninklijke Philips N.V. is a Dutch multinational public company founded in 1891 with 63,670 employees, operating across healthcare, consumer lifestyle, and lighting sectors.

    MIRION TECHNOLOGIES, INC.

    Mirion Technologies, Inc. is a United States-based public company founded in 2005 with 3,281 employees.

    DOSISOFT SA

    Dosisoft SA is a French private company founded in 2002.

    SEGAMI CORPORATION

    Segami Corporation is a Japanese private company with 1,501 employees.

    LABLOGIC SYSTEMS LTD.

    Lablogic Systems Ltd. is a United Kingdom-based private company founded in 1980.

    Reasons to Buy this Report

    • NHS Procurement Intelligence : Understand NHS capital spending patterns, tender cycles, and procurement priorities to identify opportunities for equipment sales and service contracts across England, Scotland, Wales, and Northern Ireland.
    • Competitive Landscape Analysis : Gain detailed insights into UK market competitors, their market share, product portfolios, and strategic positioning to benchmark your offerings and identify competitive advantages in the hybrid imaging segment.
    • Regional Hospital Network Mapping : Access comprehensive data on major UK hospital trusts, private healthcare providers, and specialist imaging centres to target high-value customers and understand regional equipment adoption rates and preferences.
    • Regulatory & Reimbursement Framework : Navigate UK-specific regulatory requirements, MHRA approval pathways, and NHS reimbursement policies to accelerate market entry and ensure compliance with quality standards and clinical guidelines.
    • Growth Opportunity Forecasting : Leverage detailed 5-year market projections and segment analysis to identify high-growth therapeutic areas, emerging technologies, and underserved regions within the UK market for strategic expansion planning.

    Frequently asked questions

    What is the current size of the UK nuclear medicine equipment market?

    The UK nuclear medicine equipment market is valued at $268.0 million in 2025.

    What is the projected size of the UK nuclear medicine equipment market by 2030?

    The UK nuclear medicine equipment market is projected to reach $346.0 million by 2030.

    What is the growth rate of the UK nuclear medicine equipment market?

    The UK nuclear medicine equipment market is growing at a compound annual growth rate (CAGR) of 5.2% from 2025 to 2030.

    What are the main drivers of growth in the UK nuclear medicine equipment market?

    Key drivers include the UK's aging population, rising prevalence of chronic diseases, NHS investment in diagnostic imaging, adoption of hybrid imaging technologies, and regulatory support from the MHRA.

    Which imaging technologies are most in demand in the UK nuclear medicine equipment market?

    PET-CT and SPECT-CT hybrid imaging systems are among the most in-demand technologies in the UK market, driven by their clinical efficacy and integration into NHS imaging protocols.

    RESEARCH METHODOLOGY

    This market research study involved the extensive use of secondary sources, directories, and databases to identify and collect information useful for this technical, market-oriented, and financial study of the nuclear medicine equipment market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, among other experts, to obtain and verify critical qualitative and quantitative information and to assess market prospects. The size of the nuclear medicine equipment market was estimated through various secondary research approaches and triangulated with inputs from primary research to arrive at the final market size.

    Secondary Research

    The secondary research process involved the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, company house documents, investor presentations, and SEC filings of companies. Some non-exclusive secondary sources include the World Health Organization (WHO), the Organisation for Economic Co-operation and Development (OECD), Healthcare Information and Management Systems Society (HIMSS), Centers for Disease Control and Prevention (CDC), ClinicalTrials.gov, Expert Interviews, and MarketsandMarkets Analysis.

    Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the nuclear medicine equipment market. It was also used to obtain important information about the key players and market classification and segmentation according to industry trends, to the bottom-most level, and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.

    Primary Research

    In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Primary sources are mainly industry experts from the core and related industries and preferred suppliers, manufacturers, distributors, technology developers, researchers, and organizations related to all segments of this industry’s value chain. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, among other experts, to obtain and verify the critical qualitative and quantitative information as well as assess prospects.

    Primary research was conducted to identify segmentation types, industry trends, key players, and key market dynamics such as drivers, restraints, opportunities, challenges, and strategies adopted by key players.

    After completing the market engineering process, which includes calculations for market statistics, market breakdown, size estimations, forecasting, and data triangulation, extensive primary research was conducted. This research aimed to gather information and verify the critical numbers obtained during the market analysis. Additionally, primary research was conducted to identify different types of market segmentation, analyze industry trends, evaluate the competitive landscape of nuclear medicine equipment offered by various players, and understand key market dynamics such as drivers, restraints, opportunities, challenges, industry trends, and strategies employed by key market participants.

    In the complete market engineering process, the top-down and bottom-up approaches and several data triangulation methods were extensively used to perform the market estimation and market forecasting for the overall market segments and subsegments listed in this report. Extensive qualitative and quantitative analysis was performed on the complete market engineering process to list the key information/insights throughout the report.

    Breakdown of Primary Interviews

    Nuclear Medicine Equipment Market

    Note 1: Other designations include sales, marketing, and product managers.

    Note 2: Tiers are defined based on a company’s total revenue, as of 2024: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = < USD 500 million.

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    The market size estimates and forecasts provided in this study are derived through a mix of the bottom-up approach (revenue share analysis of leading players) and top-down approach (assessment of utilization/adoption/penetration trends, by product type, therapeutic area, dimension, end user, and region).

    Nuclear Medicine Equipment Market

    Data Triangulation

    After arriving at the overall market size, from the market size estimation process explained above, the nuclear medicine equipment market was split into segments and subsegments. To complete the overall market engineering process and to arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the nuclear medicine equipment market.

    Market Definition

    Nuclear medicine equipment refers to specialized medical devices used to perform diagnostic and therapeutic procedures involving radioactive substances. These include imaging systems such as PET (Positron Emission Tomography) and SPECT (Single Photon Emission Computed Tomography) scanners, as well as gamma cameras and hybrid imaging systems. The equipment enables the detection, imaging, and tracking of radiopharmaceuticals within the body, playing a crucial role in disease diagnosis, monitoring, and targeted radionuclide therapy.

    Stakeholders

    • Nuclear Medicine Equipment Vendors & Imaging Device Manufacturers
    • Healthcare Providers (Hospitals, Outpatient Settings, Diagnostics & Imaging Centers, Radiopharmacies, Other Healthcare Providers)
    • Clinical Research Organizations (CROs)
    • Research & Development (R&D) Companies
    • Business Research & Consulting Service Providers
    • Medical Research Laboratories
    • Academic Medical Centers/Universities/Hospitals/Research Institutes
    • Regulatory Bodies (FDA, EMA, IAEA)
    • AI & Algorithm Developers
    • Venture Capitalists
    • Advocacy Groups
    • Investors & Financial Institutions
    • Contract Manufacturing Organizations (CMOs)
    • Contract Research Organizations (CROs)

    Report Objectives

    • To define, describe, and forecast the nuclear medicine equipment market by product type, therapeutic area, dimension, end user, and region
    • To provide detailed information regarding the major drivers, restraints, opportunities, and challenges influencing market growth
    • To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall nuclear medicine equipment market
    • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
    • To forecast the size of the nuclear medicine equipment market in five main regions (and their respective countries): North America, Europe, Asia Pacific, the Middle East & Africa, and Latin America
    • To provide key industry insights, such as supply chain, regulatory, patent, and recession impact analysis
    • To profile the key players in the market and comprehensively analyze their core competencies
    • To track and analyze competitive developments, such as product launches & upgrades, collaborations, partnerships, acquisitions, investments, contracts, agreements, alliances, mergers, funding, and expansions of the leading players in the market
    • To benchmark players within the market using the company evaluation matrix, which analyzes market players on various parameters within the broad categories of business strategy, market share, and product offering

    Get the Full Nuclear Medicine Equipment Market Report

    Full forecast, segment splits, and company analysis for all Nuclear Medicine Equipment Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status